Prostate in-field ablation originated in Germany and is the latest clinical method for treating prostate diseases at home and abroad. Introduction: Germany’s medical technology innovation capability is second only to the United States and is one of the countries with the strongest medical technology innovation capabilities in the world. In terms of the number of medical technology patents, Germany ranks second after the United States. Germany currently accounts for nearly 15% of the global market for medical technology products.
The prostate in-field ablation treatment system uses the powerful energy generated by high-energy focused electric fields to drive ions within tissue cells to move and produce a series of biological effects, including thermal effects, non-thermal effects, and electric field effects, thereby achieving anti-inflammatory and analgesic effects. Good results in tissue regeneration and repair.
The prostate in-field ablation treatment system creatively uses electrochemistry to completely break the barrier of the extraprostatic lipid envelope that hinders the entry of drugs and treatments. It has a unique cutting-edge MPS positioning system that tracks prostate lesions in real time. Through the application of high-energy physical fields in the cavity, the energy field is accurately sent to the lesion, producing biological effects and changing the cell arrangement of the lipid outer membrane of the prostate tubules. order, so that the drug can smoothly pass through the lipid outer membrane and enter the prostate tubules to exert its effect. Prostate diseases can be easily cured in a "simple, convenient and safe" environment.